Recent clinical trends in Toll‐like receptor targeting therapeutics

MA Anwar, M Shah, J Kim, S Choi - Medicinal research reviews, 2019 - Wiley Online Library
Toll‐like receptors (TLRs) are germline‐encoded receptors that are central to innate and
adaptive immune responses. Owing to their vital role in inflammation, TLRs are rational …

Strategies to reduce the risks of mRNA drug and vaccine toxicity

D Bitounis, E Jacquinet, MA Rogers… - Nature Reviews Drug …, 2024 - nature.com
Abstract mRNA formulated with lipid nanoparticles is a transformative technology that has
enabled the rapid development and administration of billions of coronavirus disease 2019 …

Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives

S Mukherjee, R Patra, P Behzadi, A Masotti… - Frontiers in …, 2023 - frontiersin.org
Toll-like receptors (TLRs) serve as the body's first line of defense, recognizing both
pathogen-expressed molecules and host-derived molecules released from damaged or …

Drugging membrane protein interactions

H Yin, AD Flynn - Annual review of biomedical engineering, 2016 - annualreviews.org
The majority of therapeutics target membrane proteins, accessible on the surface of cells, to
alter cellular signaling. Cells use membrane proteins to transduce signals into cells …

Small-molecule modulators of toll-like receptors

Y Wang, S Zhang, H Li, H Wang, T Zhang… - Accounts of chemical …, 2020 - ACS Publications
Conspectus Toll-like receptors (TLRs) are the “gatekeepers” of the immune system in
humans and other animals to protect the host from invading bacteria, viruses, and other …

Inhibition of RNA-binding proteins with small molecules

P Wu - Nature Reviews Chemistry, 2020 - nature.com
Protein–RNA interactions have crucial roles in various cellular activities, which, when
dysregulated, can lead to a range of human diseases. The identification of small molecules …

TRIF-dependent TLR signaling, its functions in host defense and inflammation, and its potential as a therapeutic target

MO Ullah, MJ Sweet, A Mansell… - Journal of Leucocyte …, 2016 - academic.oup.com
Abstract Toll/IL-1R domain-containing adaptor-inducing IFN-β (TRIF)-dependent signaling is
required for TLR-mediated production of type-I IFN and several other proinflammatory …

Toll-like receptor (TLRs) agonists and antagonists for COVID-19 treatments

ZM Liu, MH Yang, K Yu, ZX Lian… - Frontiers in Pharmacology, 2022 - frontiersin.org
Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) rapidly infects
humans and animals which make coronavirus disease 2019 (COVID-19) a grievous …

Toll-like receptors and chronic inflammation in rheumatic diseases: new developments

LAB Joosten, S Abdollahi-Roodsaz… - Nature Reviews …, 2016 - nature.com
In the past few years, new developments have been reported on the role of Toll-like
receptors (TLRs) in chronic inflammation in rheumatic diseases. The inhibitory function of …

Small-molecule modulators targeting toll-like receptors for potential anticancer therapeutics

J Wang, J Zhang, J Wang, X Hu… - Journal of Medicinal …, 2023 - ACS Publications
Toll-like receptors (TLRs) are key components of the innate immune system and serve as a
crucial link between innate and acquired immunity. In addition to immune function, TLRs are …